Alkermes announces CEO succession plan
Source: SeekingAlpha
2026-02-25 07:47:17 ET
More on Alkermes
- 44th Annual J.P. Morgan Healthcare Conference
- Alkermes plc (ALKS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Alkermes: Avadel Deal And Vibrance-2 Unlock Upside
- Alkermes GAAP EPS of $0.29 misses by $0.05, revenue of $384.5M beats by $3.01M
- Alkermes Q4 2025 Earnings Preview
Read the full article on Seeking Alpha
For further details see:
Alkermes announces CEO succession plan
Alkermes plc
NASDAQ: ALKS
ALKS Trading
-1.63% G/L:
$28 Last:
757,528 Volume:
$27.91 Open:
ALKS Latest News
ALKS Stock Data
$5,792,322,216
157,043,263
0.1%
131
N/A
Pharmaceuticals
Healthcare
IE
Dublin 4
